Researchers Analyzed European Cholera Cases
Scientists evaluated 50 bacterial isolates from 59 cholera cases reported in Europe during 2023 and 2024.
Updated on Sept. 24, 2026 in Life Sciences

A recent study investigated 50 Vibrio cholerae O1 isolates linked to 59 cholera cases reported across 11 European countries in 2023 and 2024. Researchers utilized whole genome sequencing to characterize the bacteria and confirm their lineage.
Why it matters
Understanding the genetic makeup of these isolates helps health officials track the spread of the seventh pandemic El Tor lineage. Identifying drug-resistant strains is critical for managing potential outbreaks and ensuring effective medical responses.
Analysis confirmed all 49 usable genomes belong to the seventh pandemic El Tor lineage, with 33 isolates classified as the Pre-AFR15 sub-lineage. Researchers compared these samples against over 1,500 publicly available genomes to determine their relationships.
The players
Vibrio cholerae O1
This is the specific bacterium responsible for cholera outbreaks, which has been circulating globally in a seventh pandemic El Tor lineage.
The details
The study focused on characterizing virulence and antimicrobial resistance markers to understand how the bacteria are evolving. Eight of the analyzed isolates showed resistance to multiple first-line antimicrobial agents, highlighting a concerning trend for public health surveillance.
Timeline
The cholera cases were reported throughout 2023 and 2024.
The Big Picture
This study follows the established patterns of genomic characterization maintained by the seventh pandemic El Tor lineage surveillance initiative. By mapping these specific isolates, researchers provide a clearer view of how the pathogen evolves and spreads globally.
The identification of drug-resistant strains underscores the necessity for medical providers to remain vigilant about antimicrobial resistance in diarrheal illnesses. This research supports the development of more accurate diagnostic tests and treatment protocols for future cases.
The takeaway
The presence of drug-resistant cholera strains in Europe emphasizes that even non-endemic regions must maintain robust genomic surveillance. Monitoring these genetic markers allows global health systems to respond quickly if resistant lineages begin to spread more broadly.
Further reading
Learn more about the latest research in Life Sciences.
Source note: This article includes information reported by Biorxiv.



